84.71
84.71 (0%)
As of Apr 29, 2025
Merck & Co Inc [MRK]
Source:
Company Overview
Merck & Co., Inc is a global health care company that delivers innovative health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products.
| Country | United States |
| Headquarters | rahway, new jersey |
| Phone Number | (908) 740-4000 |
| Industry | manufacturing |
| CEO | Robert M. Davis |
| Website | merck.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $64,168 |
| Operating Profit | |
| Net Income | $17,133 |
| Net Cash | $6,409 |
Profit Ratios
| Gross Margin | $48,975 |
| Operating Margin | |
| Profit as % of Revenues | 285.9% |
| Profit as % of Assets | 15.3% |
| Profit as % of Stockholder Equity | 37% |
Management Effectiveness
| Return on Equity | 37% |
| Return on Assets | 14.6% |
| Turnover Ratio | 57.4% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $117,106 |
| Total Liabilities | $70,734 |
| Operating Cash Flow | $21,468 |
| Investing Cash Flow | $-7,734 |
| Financing Cash Flow | $-7,032 |
